Brazilian researchers have created an affordable biosensor to detect altered levels of a protein linked to mental disorders like major depressive disorder and schizophrenia, enhancing early diagnosis and treatment.
- The portable biosensor identifies changes in the brain-derived neurotrophic factor protein, which is crucial for understanding mental disorders, particularly major depressive disorder and schizophrenia.
- Developed by a team from the University of São Paulo (USP), this biosensor utilizes saliva to provide quick results, making it accessible for broader patient monitoring in Brazil.
- With potential commercial availability, this innovative biosensor could revolutionize the early detection and management of bipolar disorder and other mental disorders, ultimately improving patient outcomes.
Why It Matters
The development of this biosensor represents a significant step toward affordable and accessible mental health diagnostics. By enabling early detection of conditions such as major depressive disorder and schizophrenia, it has the potential to improve treatment efficacy and patient quality of life.